Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement
Vaccines · 22.01.2025 · 13 (2) · 107
DOI: 10.3390/vaccines13020107 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 22.01.2025. Verfasst von Sławomir Lewicki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Pl. Żelaznej Bramy 10, 00-136 Warsaw, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a prevalent chronic condition associated with substantial global morbidity and mortality. Primarily caused by prolonged exposure to harmful agents such as dust and gases, COPD is characterized by persistent airflow limitation, clinically manifesting as chronic cough, sputum production, and dyspnea. The disease course alternates between stable phases and exacerbations, with the latter often associated with pathogenic colonization of the respiratory tract. This review examines the immunological underpinnings of COPD, emphasizing the interplay between innate and adaptive immunity in disease pathogenesis. Dysregulated immune responses to environmental factors perpetuate chronic inflammation, resulting in progressive pulmonary epithelial damage and connective tissue hyperplasia, which compromise gas exchange. Exacerbations further exacerbate respiratory failure, aggravating patient symptoms and accelerating disease progression. Despite advances in COPD management, effective therapeutic options remain limited. Current treatments primarily aim to alleviate symptoms, reduce immune activation, and manage infections, yet many patients experience suboptimal outcomes. This review highlights the potential of novel therapeutic approaches targeting immune system cells and pathways. In particular, it explores the promise of oral bacterial vaccines as immunomodulatory agents to enhance immune responses and improve clinical outcomes in COPD, addressing critical gaps in current treatment paradigms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Pl. Żelaznej Bramy 10, 00-136 Warsaw, Poland.
- Department of Environmental Threat Prevention, Allergology and Immunology, Faculty of Health Sciences, Medical University of Warsaw, Pawińskiego 3c, 02-106 Warsaw, Poland.
- Department of Dietetics, Institute of Human Nutrition Science, Warsaw University of Life Sciences, Nowoursynowska 159c St., 02-776 Warsaw, Poland.
- Department of Histology and Embryology, Medical University of Warsaw, Chałubińskiego 5, 02-004 Warsaw, Poland.
- Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, 05-552 Magdalenka, Poland.
- Hull University Teaching Hospitals NHS Trust, Hull University, Anlaby Rd., Hull HU3 2JZ, UK.
ORCID-Profile: Sławomir Lewicki, Łukasz Szymański, Łukasz Szarpak
Zitieren
APA
Lewicki, S., Bałan, B. J., Stelmasiak, M., Radomska-Leśniewska, D. M., Szymański, Ł., Rios-Turek, N., Bień-Kalinowska, J., Szarpak, Ł., & Hajduk, B. (2025). Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement. Vaccines, 13(2), 107. https://doi.org/10.3390/vaccines13020107
Vancouver
Lewicki S, Bałan BJ, Stelmasiak M, Radomska-Leśniewska DM, Szymański Ł, Rios-Turek N, et al. Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement. Vaccines. 2025;13(2):107. doi:10.3390/vaccines13020107
BibTeX
@article{Lewicki2025,
author = {Lewicki, Sławomir and Bałan, Barbara Joanna and Stelmasiak, Marta and Radomska-Leśniewska, Dorota Magdalena and Szymański, Łukasz and Rios-Turek, Natalia and Bień-Kalinowska, Justyna and Szarpak, Łukasz and Hajduk, Bogdan},
title = {Immunological Insights and Therapeutic Advances in COPD: Exploring Oral Bacterial Vaccines for Immune Modulation and Clinical Improvement},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {2},
pages = {107},
doi = {10.3390/vaccines13020107}
}
EUVIMED